Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | +5.95% | +25.35% | +28.99% |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
Apr. 24 | Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.99% | 326M | |
+1.85% | 42.75B | |
+47.70% | 41.61B | |
+12.43% | 41.34B | |
-8.83% | 26.59B | |
+7.52% | 25.49B | |
-23.07% | 18.12B | |
+30.55% | 12.24B | |
-2.03% | 11.76B | |
+8.19% | 11B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Secures 1.6 Million Euro French R&D Tax Rebate for 2022